SCHEMBL155349

SCHEMBL155349

OC12CCC(CC1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8646647 1.00
SCHEMBL6364065 1.00
SCHEMBL155497 0.89
SCHEMBL2288427 0.87
SCHEMBL151704 0.87
SCHEMBL154814 0.81 PKM (0.31)
SCHEMBL4948790 0.79 PKM (0.39)
Methane SCHEMBL15974539 0.79 PKM (0.30)
SCHEMBL155313 0.79
SCHEMBL157035 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325673-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2025-10-23 US claimed
EP-4613773-A2 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-09-10 EP claimed
CN-119002096-A Method for manufacturing contact lens 望隼科技股份有限公司 2024-11-22 CN claimed
US-20240261353-A1 BIOACTIVE CONCENTRATES AND USES THEREOF Purple Mondo, Inc. 2024-08-08 US claimed
US-20230132715-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-05-04 US claimed
EP-3322291-B1 ANTIMICROBIAL COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2023-04-12 EP claimed
CN-114437288-B Filtrate reducer for drilling fluid and preparation method and application thereof 中国石油化工股份有限公司 2023-04-11 CN claimed
EP-4137142-A1 BIOACTIVE CONCENTRATES AND USES THEREOF Purple Mundo, Inc. (US) 2023-02-22 EP claimed
US-20220331297-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 POLYPEPTIDES ARVINAS OPERATIONS, INC. 2022-10-20 US claimed
EP-2968259-B1 BIOACTIVE CONCENTRATES AND USES THEREOF SC LABORATORIES INC (US) 2022-09-14 EP claimed
US-6245774-B1 ANTIINFLAMMATORY AGENTS; BRONCHODILATOR AGENTS CELLTECH THERAPEUTICS LIMITED (GB) 2001-06-12 US claimed
US-6022968-A Processes for the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-tetrahydr opyrimidin-2(1H)-one PFIZER INC (US) 2000-02-08 US claimed
EP-0908744-A1 Silicone hydrogel polymers JOHNSON &amp; JOHNSON VISION PRODUCTS, INC. (US) 1999-04-14 EP claimed
EP-0570593-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE NORBORNEOL SHIONOGI & CO (JP) 1998-09-09 EP claimed
WO-1998034603-A1 USE OF BETULIN AND ANALOGS THEREOF TO TREAT HERPESVIRUS INFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1998-08-13 WO claimed
EP-0775119-A1 PROCESSES AND INTERMEDIATES IN THE SYNTHESIS OF 5-(3- EXO-BICYCLO 2.2.1]HEPT-2-YLOXY]-4-METHOXYPHENYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-2(1H)-ONE PFIZER INC. (US) 1997-05-28 EP claimed
WO-1996004253-A1 PROCESSES AND INTERMEDIATES IN THE SYNTHESIS OF 5-(3-[EXO-BICYCLO[2.2.1]HEPT-2-YLOXY]-4-METHOXYPHENYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-2(1H)-ONE PFIZER INC. (US) 1996-02-15 WO claimed
US-5459067-A In presence of microorganism, Arthrobacter SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1995-10-17 US claimed
EP-0667857-A1 INDOLYLCARBAMATES AS ANTI-INFLAMMATORY AGENTS PFIZER INC. (US) 1995-08-23 EP claimed
WO-1994010144-A1 INDOLYLCARBAMATES AS ANTI-INFLAMMATORY AGENTS PFIZER INC. (US) 1994-05-11 WO claimed